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Front cover image: The scheme represents 
a combination of graphical elements illustrative 
of how mutations at the flavin binding site 
(bottom) affecting the Drosophila ETF:QO 
protein (left) result in embryonic defects in the 
fly (center) and a phenotype which resembles 
that of the rare metabolic human disease MADD. 
Based on figures from Alves, E., Henriques, 
B.J., Rodrigues, J.V., Prudêncio, P., Rocha, 
H., Vilarinho, L., Martinho, R.G. and Gomes, 
C.M. ‘Mutations at the flavin binding site of 
ETF:QO yield a MADD-like severe phenotype in 
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